A detailed history of Prudential Financial Inc transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 26,400 shares of AADI stock, worth $57,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,400
Holding current value
$57,288
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.32 - $2.06 $34,848 - $54,384
26,400 New
26,400 $54,000
Q1 2024

May 14, 2024

BUY
$1.59 - $2.44 $33,954 - $52,106
21,355 New
21,355 $49,000

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $45.6M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.